Avai Bio (AVAI) Depreciation & Amortization (CF) (2018 - 2026)

Avai Bio (AVAI) has 9 years of Depreciation & Amortization (CF) data on file, last reported at $6518.0 in Q1 2026.

• For the quarter ending Q1 2026, Depreciation & Amortization (CF) fell 58.66% year-over-year to $6518.0; the trailing twelve-month figure through Mar 2026 stood at $26070.0 (down 64.92% YoY), and the FY2026 full-year result was $26070.0, down 64.92% from the prior year.
• Depreciation & Amortization (CF) was little changed at $6518.0 in Q1 2026, from $6517.0 in the prior quarter.
• In the past five years, Depreciation & Amortization (CF) ranged from a high of $47267.0 in Q1 2024 to a low of $3825.0 in Q3 2022.
• A 5-year average of $12511.8 and a median of $10268.0 in 2023 frame the typical range for Depreciation & Amortization (CF).
• Across the five-year window, Depreciation & Amortization (CF) tumbled 72.05% in 2022 and surged 1135.74% in 2024, its largest moves.
• Tracing AVAI's Depreciation & Amortization (CF) over 5 years: stood at $3825.0 in 2022, then soared by 168.44% to $10268.0 in 2023, then jumped by 90.09% to $19518.0 in 2024, then sank by 66.61% to $6517.0 in 2025, then increased by 0.02% to $6518.0 in 2026.
• Business Quant data shows AVAI's Depreciation & Amortization (CF) at $6518.0 in Q1 2026, $6517.0 in Q4 2025, and $6517.0 in Q3 2025.